NYU Begins Psilocybin-Alcoholism Study

The NYU School of Medicine starts a clinical trial to assess the effects of psilocybin-assisted therapy on people with alcohol use disorder.

February 2018

Researchers at the NYU School of Medicine have started a double-blind placebo-controlled clinical trial on the psilocybin-assisted treatment of alcohol use disorder. Although he study is not complete, the researchers thought some of their qualitative findings thus far were interesting enough to publish. They found that for the patients on psilocybin “…pivotal moments tend to be individualized, extremely vivid, and memorable.” They go on to report that the patients “…experienced acute and lasting alterations in their perceptions of self, in the quality of their baseline consciousness, and in their relationship with alcohol and drinking.” The patients described feelings of increased “spaciousness” (mindfulness), and increased control over their choices and behavior.